Savvy Advisors, Inc.

Position in AMGN — Amgen Inc

CIK 2003633 NEW YORK, NY

Position in AMGN

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$3,210,555

+$443,255 QoQ

Shares Held

8,866

+12.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#1,040

of 3,140 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Savvy Advisors, Inc. holds $76,177,926 across 13 Drug Manufacturers - General names. AMGN ranks #6 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	21,784	$26,128,385
2	ABBV	AbbVie Inc.	60,465	$15,215,412
3	JNJ	Johnson & Johnson	51,624	$13,110,947
4	MRK	Merck & Co., Inc.	46,232	$5,940,812
5	BMY	Bristol Myers Squibb Co	64,644	$3,724,787
6	AMGN	Amgen Inc This page	8,866	$3,210,555
7	NVS	Novartis AG	13,331	$2,089,234
8	GILD	Gilead Sciences, Inc.	15,259	$1,927,822

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,210,555	8,866	+12.7%	Shares	Sole	2026-08-03
2026-03-31	$2,767,300	7,865	-14.4%	Shares	Sole	2026-05-11
2025-12-31	$3,006,015	9,184	+20.8%	Shares	Sole	2026-01-20
2025-09-30	$2,145,566	7,603	-83.5%	Shares	Sole	2025-11-06
2025-06-30	$12,829,699	45,950	+1.2%	Shares	Sole	2025-08-04
2025-03-31	$14,146,862	45,408	+5.7%	Shares	Sole	2025-05-12
2024-12-31	$11,191,881	42,940	+5.1%	Shares	Sole	2025-02-13
2024-09-30	$13,163,245	40,853	-1.1%	Shares	Sole	2024-11-05
2024-06-30	$12,904,809	41,302	+4.8%	Shares	Sole	2024-08-14
2024-03-31	$11,202,208	39,400	+0.3%	Shares	Sole	2024-05-13
2023-12-31	$11,318,321	39,297	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.